DVAX News and Press, Dynavax Technologies Corporation From 03/22/24

2024-03-22 01:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-03-11 23:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Dynavax to Present at TD Cowen's 44th Annual Health Care Conference PR Newswire EMERYVILLE, Calif. , Feb. 27, 2024 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializin...

2024-02-22 20:00:16 ET Image source: The Motley Fool. Dynavax Technologies (NASDAQ: DVAX) Q4 2023 Earnings Call Feb 22, 2024 , 4:30 p.m. ET Operator Continue reading For further details see: Dynavax Technologies (DVAX) Q4 2023 Earnings Call Tr...

2024-02-22 19:34:06 ET Dynavax Technologies Corporation (DVAX) Q4 2023 Earnings Conference Call February 22, 2024 04:30 PM ET Company Participants Paul Cox - Vice President, Investor Relations & Corporate Communications Ryan Spencer - Chief Executive Officer ...

2024-02-22 16:02:21 ET More on Dynavax Dynavax Technologies: Still A Solid Pick For 2024 Dynavax reports 46% Y/Y increase in HEPLISAV-B vaccine net product revenue Seeking Alpha’s Quant Rating on Dynavax Historical earnings data for Dynavax Fin...

Dynavax Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Financial Guidance PR Newswire HEPLISAV-B ® 2023 net product revenue grew 69% year-over-year to $213 million Achieved market leader status in key seg...

2024-02-21 17:20:36 ET More on Dynavax Dynavax Technologies: Still A Solid Pick For 2024 Dynavax reports 46% Y/Y increase in HEPLISAV-B vaccine net product revenue Seeking Alpha’s Quant Rating on Dynavax Historical earnings data for Dynavax Fin...

2024-02-16 11:10:43 ET More on iShares Russell 2000 ETF: IWM: Technical Analysis Says You Should Buy Small Caps IWM: Supply-Side Disinflation Benefits Small Caps The Most Small-Cap ETFs: Performance, Fundamentals, And Rankings For 102 Funds Investors retract ...

2024-02-08 20:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...